![Lisa Bollinger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lisa Bollinger
Director/Board Member at
APOGEE THERAPEUTICS, INC.
Net worth: 952 $ as of 2026-06-29
Profile
Lisa L.
Bollinger is currently an Independent Director at Apogee Therapeutics, Inc. since 2024.
Formerly, Dr. Bollinger was VP-Regulatory Affairs & Global Regulatory Affairs at Merck & Co., Inc. from 2021 to 2024, Vice President-Global Regulatory Affairs, R&D at Amgen, Inc. from 2018 to 2021, Associate Director-New Drug at the Center for Drug Evaluation & Research, and Chief Medical Officer at Polaryx Therapeutics, Inc. from 2025 to 2026.
Education includes a doctorate from Uniformed Services University of the Health Sciences and an undergraduate degree from the University of California.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-02-01 | 358 ( 0% ) | 952 $ | 2026-06-29 | |
| 2026-07-09 | 0 ( -.--% ) | - $ | 2026-06-29 |
Lisa Bollinger active positions
| Companies | Position | Start |
|---|---|---|
| APOGEE THERAPEUTICS, INC. | Director/Board Member | 2024-05-27 |
Former positions of Lisa Bollinger
| Companies | Position | End |
|---|---|---|
| POLARYX THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2026-07-18 |
| MERCK & CO., INC. | General Counsel | 2024-04-30 |
| AMGEN INC. | Chief Tech/Sci/R&D Officer | 2021-02-28 |
Center for Drug Evaluation & Research
 Center for Drug Evaluation & Research General GovernmentGovernment Operates agencies for the department of health and human services | Corporate Officer/Principal | - |
Training of Lisa Bollinger
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
70
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Uniformed Services University of the Health Sciences
 Uniformed Services University of the Health Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Center for Drug Evaluation & Research
Center for Drug Evaluation & Research General GovernmentGovernment Operates agencies for the department of health and human services | Government |
University of California
 University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Polaryx Therapeutics, Inc.
 Polaryx Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that engages in discovery, development and commercialization of novel, disease-modifying therapies for rare, pediatric lysosomal storage disorders | Commercial Services |
Apogee Therapeutics, Inc.
 Apogee Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops therapies for immunological and inflammatory disorders | Health Technology |
- Stock Market
- Insiders
- Lisa Bollinger
